Evidence map›Paper›PMID 29127133›Full record

ArticleBMJ case reports2017

Nephrotic syndrome and acute kidney injury induced by malathion toxicity.

Kei Yokota, Masamichi Fukuda, Ritsuko Katafuchi, Tadashi Okamoto

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Molecular Mechanisms of Acute Organophosphate Nephrotoxicity.International journal of molecular sciences · 2022
    Review
  5. Article
  6. GinsengLife (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Association of Pesticides and Kidney Function among Adults in the US Population 2001-2010.International journal of environmental research and public health · 2021
    Article
  9. Article
  10. Review
  11. Protective effects of thymoquinone and diallyl sulphide against malathion-induced toxicity in rats.Environmental science and pollution research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kei YokotaDepartment for Support of Rural Medicine, Yamaguchi Grand Medical Center, Hofu, Japan.
Masamichi FukudaDepartment of Nephrology, Iwakuni Medical Center, Iwakuni, Japan.
Ritsuko KatafuchiDepartment of Nephrology, Fukuoka Higashi Medical Center, Koga, Japan.
Tadashi OkamotoDepartment of Nephrology, Shunan City Shinnanyo Hospital, Shunan, Japan.
Fukuoka Higashi Medical Center · JPIwakuni Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We treated a case of acute kidney injury and nephrotic syndrome after malathion inhalation. A 69-year-old Japanese man presented with oedema 15 days after inhalation of malathion, a widely used pesticide. Serum albumin was 2.4 g/dL, urinary protein 8.6 g/gCr and serum creatinine 2.5 mg/dL. Kidney biopsy revealed tubular cell damage, epithelial cell damage in glomeruli and diffuse foot process effacement in electron microscopy. Acute kidney injury progressed to treatment with dialysis. Renal function recovered after corticosteroid administration from the 43rd day after admission. Malathion inhalation should be ruled out as a differential diagnosis in individuals who develop acute kidney injury and nephrotic syndrome, especially in rural-dwelling patients.

Indexed as

Acute Kidney InjuryAgedDiagnosis, DifferentialHumansMalathionMaleNephrotic SyndromePesticidesRenal DialysisMalathionPesticidesacute renal failurenephrotic syndromeproteinurearenal medicinetoxicology

Identifiers

PMID29127133
PMCPMC5695491
OpenAlexW2767424171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.